163 related articles for article (PubMed ID: 12791472)
1. Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.
Waites KB; Crabb DM; Duffy LB
Int J Antimicrob Agents; 2003 Jun; 21(6):574-7. PubMed ID: 12791472
[TBL] [Abstract][Full Text] [Related]
2. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
Hannan PC; Woodnutt G
J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
Lemmen S; Al-Lahham A; Lütticken R; Reinert RR
Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811
[TBL] [Abstract][Full Text] [Related]
5. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
6. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
7. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.
Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
Antimicrob Agents Chemother; 1999 Nov; 43(11):2806-7. PubMed ID: 10543770
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.
Higgins PG; Coleman K; Amyes SG
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():71-7. PubMed ID: 10824036
[TBL] [Abstract][Full Text] [Related]
11. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
Naber KG; Hollauer K; Kirchbauer D; Witte W
Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae.
Hamamoto K; Shimizu T; Fujimoto N; Zhang Y; Arai S
Antimicrob Agents Chemother; 2001 Jun; 45(6):1908-10. PubMed ID: 11353651
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
LaPlante KL; Rybak MJ; Tsuji B; Lodise TP; Kaatz GW
Antimicrob Agents Chemother; 2007 Apr; 51(4):1315-20. PubMed ID: 17296740
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
Kerawala M; Ambler JE; Lee PY; Drabu YJ
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
[TBL] [Abstract][Full Text] [Related]
17. A comparative In vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research Group.
Hoban DJ; Bouchillon SK; Karlowsky JA; Johnson JL; Butler DL; Miller LA; Poupard JA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3008-11. PubMed ID: 11036014
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
Morrissey I; George JT
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():107-10. PubMed ID: 10824041
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.
Ieven M; Goossens W; De Wit S; Goossens H
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():51-3. PubMed ID: 10824033
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of 4903 bacterial isolates to gemifloxacin--an advanced fluoroquinolone.
Blondeau JM; Hansen G; Metzler KL; Borsos S; Irvine LB; Blanco L
Int J Antimicrob Agents; 2003 Aug; 22(2):147-54. PubMed ID: 12927955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
